OTCM
RMSL
Market cap12mUSD
Jul 11, Last price
0.01USD
1D
-5.95%
1Q
-14.59%
IPO
-96.84%
Name
REMSleep Holdings Inc
Chart & Performance
P/E
—
P/S
59.54
EPS
—
Div Yield, %
—
Shrs. gr., 5y
224.45%
Rev. gr., 5y
%
Revenues
204k
-36.48%
Net income
-2m
L+17.13%
CFO
-791k
L-64.58%
Earnings
Aug 18, 2025
Profile
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Tampa, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 204 -36.48% | 321 | |||||||
Cost of revenue | 1,975 | 1,539 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,772) | (1,218) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 31 | ||||||||
Tax Rate | |||||||||
NOPAT | (1,772) | (1,249) | |||||||
Net income | (1,778) 17.13% | (1,518) -68.01% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 855 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 134 | 272 | |||||||
Long-term debt | 222 | 450 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (363) | (1,120) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (791) | (2,234) | |||||||
CAPEX | (148) | (122) | |||||||
Cash from investing activities | (148) | (122) | |||||||
Cash from financing activities | (184) | 815 | |||||||
FCF | (844) | (2,451) | |||||||
| Balance | |||||||||
Cash | 719 | 1,842 | |||||||
Long term investments | |||||||||
Excess cash | 709 | 1,826 | |||||||
Stockholders' equity | (12,818) | (11,043) | |||||||
Invested Capital | 13,927 | 14,202 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 1,461,617 | 1,461,966 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (1,669) | (1,157) | |||||||
EV/EBITDA | |||||||||
Interest | 7 | 237 | |||||||
Interest/NOPBT | |||||||||